(Q38324833)

2 September 2017

title

Synthetic oligosaccharides having various functional domains: potent and potentially safe heparin mimetics (English)

1 reference

2 September 2017

1 reference

Petitou M

1

1 reference

2 September 2017

Driguez PA

2

1 reference

2 September 2017

Duchaussoy P

3

1 reference

2 September 2017

Hérault JP

4

1 reference

2 September 2017

Lormeau JC

5

1 reference

2 September 2017

Herbert JM

6

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 April 1999

1 reference

Bioorganic & Medicinal Chemistry Letters

2 September 2017

published in

1 reference

2 September 2017

volume

9

1 reference

2 September 2017

issue

8

1 reference

2 September 2017

page(s)

1161-1166

1 reference

The structure of heparin oligosaccharide fragments with high anti-(factor Xa) activity containing the minimal antithrombin III-binding sequence Chemical and13C nuclear-magnetic-resonance studies

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900156-0

7 January 2021

Further characterization of the antithrombin-binding sequence in heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900156-0

7 January 2021

Structure-activity relationship in heparin: a synthetic pentasaccharide with high affinity for antithrombin III and eliciting high anti-factor Xa activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900156-0

7 January 2021

Structure and biological activity of heparin.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900156-0

7 January 2021

The clot thickens: clues provided by thrombin structure.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900156-0

7 January 2021

Regulation of thrombin activity by antithrombin and heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900156-0

7 January 2021

A model of the platelet factor 4 complex with heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900156-0

7 January 2021

Rational design of synthetic heparin analogues with tailor-made coagulation factor inhibitory activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900156-0

7 January 2021

Feasible synthesis and biological properties of six 'non-glycosamino' glycan analogues of the antithrombin III binding heparin pentasaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900156-0

7 January 2021

First Synthetic Carbohydrates with the Full Anticoagulant Properties of Heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900156-0

7 January 2021

New synthetic heparin mimetics able to inhibit thrombin and factor Xa.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900156-0

7 January 2021

A convenient synthesis of quinones from hydroquinone dimethyl ethers. Oxidative demethylation with ceric ammonijm nitrate

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900156-0

7 January 2021

Protection of hydroxyl groups as tert-butyldimethylsilyl derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900156-0

7 January 2021

Synthesis and pharmacological properties of a close analogue of an antithrombotic pentasaccharide (SR 90107A/ORG 31540).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900156-0

7 January 2021

Contribution of 3-O- and 6-O-sulfated glucosamine residues in the heparin-induced conformational change in antithrombin III

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900156-0

7 January 2021

Evaluation of an amidolytic heparin assay method: increased sensitivity by adding purified antithrombin III

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900156-0

7 January 2021

Biochemical and pharmacological properties of SANORG 32701. Comparison with the "synthetic pentasaccharide' (SR 90107/ORG 31540) and standard heparin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-894X%2899%2900156-0

7 January 2021

10.1016/S0960-894X(99)00156-0

Identifiers

DOI

1 reference

release_5nzh73sgejbofl7voirolvx3ie

2 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/5nzh73sgejbofl7voirolvx3ie

24 November 2022

mapped directly with Wikidata item

1 reference